Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.

S. Derer; S. Berger; M. Schlaeth; T. Schneider-Merck; K. Klausz; S. Lohse; M. Overdijk; M. Dechant; C. Kellner; I. Nagelmeier; A.H. Scheel; J.J. Lammerts van Bueren; J.G. van de Winkel; P.W.H.I. Parren; M. Peipp; T. Valerius

Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.

S. Derer, S. Berger, M. Schlaeth, T. Schneider-Merck, K. Klausz, S. Lohse, M. Overdijk, M. Dechant, C. Kellner, I. Nagelmeier, A.H. Scheel, J.J. Lammerts van Bueren, J.G. van de Winkel, P.W.H.I. Parren, M. Peipp, T. Valerius

Utrecht University

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	190-205
Number of pages	16
Journal	Neoplasia
Volume	14
Issue number	3
Publication status	Published - 2013

Bibliographical note

geen aff. UMCUtrecht - Genmab
6th Dutch North Sea Emergency Medicine Conference, Egmond aan Zee, Nederland

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22496619

Cite this

Derer, S., Berger, S., Schlaeth, M., Schneider-Merck, T., Klausz, K., Lohse, S., Overdijk, M., Dechant, M., Kellner, C., Nagelmeier, I., Scheel, A. H., Lammerts van Bueren, J. J., van de Winkel, J. G., Parren, P. W. H. I., Peipp, M., & Valerius, T. (2013). Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression. Neoplasia, 14(3), 190-205. http://www.ncbi.nlm.nih.gov/pubmed/22496619

@article{e45791face714717b373757695c2d633,

title = "Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.",

author = "S. Derer and S. Berger and M. Schlaeth and T. Schneider-Merck and K. Klausz and S. Lohse and M. Overdijk and M. Dechant and C. Kellner and I. Nagelmeier and A.H. Scheel and {Lammerts van Bueren}, J.J. and {van de Winkel}, J.G. and P.W.H.I. Parren and M. Peipp and T. Valerius",

note = "geen aff. UMCUtrecht - Genmab 6th Dutch North Sea Emergency Medicine Conference, Egmond aan Zee, Nederland",

year = "2013",

language = "Undefined/Unknown",

volume = "14",

pages = "190--205",

journal = "Neoplasia",

issn = "1522-8002",

publisher = "Elsevier Inc.",

number = "3",

}

Derer, S, Berger, S, Schlaeth, M, Schneider-Merck, T, Klausz, K, Lohse, S, Overdijk, M, Dechant, M, Kellner, C, Nagelmeier, I, Scheel, AH, Lammerts van Bueren, JJ, van de Winkel, JG, Parren, PWHI, Peipp, M & Valerius, T 2013, 'Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.', Neoplasia, vol. 14, no. 3, pp. 190-205. <http://www.ncbi.nlm.nih.gov/pubmed/22496619>

TY - JOUR

T1 - Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.

AU - Derer, S.

AU - Berger, S.

AU - Schlaeth, M.

AU - Schneider-Merck, T.

AU - Klausz, K.

AU - Lohse, S.

AU - Overdijk, M.

AU - Dechant, M.

AU - Kellner, C.

AU - Nagelmeier, I.

AU - Scheel, A.H.

AU - Lammerts van Bueren, J.J.

AU - van de Winkel, J.G.

AU - Parren, P.W.H.I.

AU - Peipp, M.

AU - Valerius, T.

N1 - geen aff. UMCUtrecht - Genmab 6th Dutch North Sea Emergency Medicine Conference, Egmond aan Zee, Nederland

PY - 2013

Y1 - 2013

M3 - Article

SN - 1522-8002

VL - 14

SP - 190

EP - 205

JO - Neoplasia

JF - Neoplasia

IS - 3

ER -